Your browser doesn't support javascript.
loading
Sodium-glucose cotransporter 2 inhibitors: A comprehensive review from cells to bedside.
Bagheri, Bahador; Yaribeygi, Habib; Taherifard, Erfan; Talasaz, Azita Hajhossein; Bagheri, Haleh; Darban, Mahboubeh; Tabrizi, Reza; Najafi, Siamak; Khodadost, Mahmoud; Akbari, Maryam.
Affiliation
  • Bagheri B; Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Yaribeygi H; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
  • Taherifard E; Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
  • Talasaz AH; Department of Internal Medicine, Shiraz University of Medical Sciences, Fars, Iran.
  • Bagheri H; Department of Pharmacotherapy and Outcome Sciences, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Darban M; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.
  • Tabrizi R; Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran.
  • Najafi S; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
  • Khodadost M; USERN office, Fasa University of Medical Sciences, Fasa, Iran.
  • Akbari M; Clinical Research Development Unit, Fasa University of Medical Sciences, Fasa, Iran.
Fundam Clin Pharmacol ; 37(3): 481-492, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36399066
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Limits: Humans Language: En Journal: Fundam Clin Pharmacol Journal subject: FARMACOLOGIA Year: 2023 Type: Article Affiliation country: Iran
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Limits: Humans Language: En Journal: Fundam Clin Pharmacol Journal subject: FARMACOLOGIA Year: 2023 Type: Article Affiliation country: Iran